Girl was successfully treated with gene editing drug manufactured in China


Beijing: A four-year-old Pakistani girl, Aiza, suffering from Thalassemia Major, was successfully treated in China.
The hospital administration said that a base editing drug called CS-101 was used in the treatment of thalassemia major. The girl was successfully treated with a gene editing drug manufactured in China, after which the girl will now be able to lead a normal life, while this technology was used for the first time on a foreign minor.
The hospital administration also organized a ceremony to celebrate the girl’s recovery.
According to the administration, the girl had arrived in Shanghai with her parents in January for treatment.
According to the administration, four patients, including Aiza, have received this therapy so far. The success of gene editing therapy has given a ray of hope to patients suffering from this disease around the world.

Eidul Adha in Saudi Arabia to be celebrated on June 6
- 2 hours ago
Bangladesh SC acquits JI leader Azharul Islam, cancels death penalty
- 5 hours ago

UK launches £3bn skills training plan to cut reliance on migrant labour
- 4 hours ago
Pakistan, Iran eye closer military and economic cooperation
- 7 hours ago
Rupee under pressure as dollar hits Rs284.40 in open market
- 5 hours ago
Explosion at China chemical plant kills 5, 6 missing
- 5 hours ago
CII rejects bill banning marriage under 18
- 6 hours ago
Cardinal Joseph Coutts meets minority rights activists in Karachi
- 7 hours ago
Pakistan vs Bangladesh: T20 series trophy unveiled in Lahore
- 4 hours ago

Punjab govt to hike traffic fines by 10 times, launch major reforms
- 7 hours ago
Eid-ul-Adha in Pakistan to be celebrated on June 7
- 4 hours ago

Gold prices continue to drop for second consecutive day
- 6 hours ago